Navigation Links
JS Genetics announces launch of XCAT-KS, a bloodless, cheek swab test for the diagnosis of Klinefelter syndrome and other Male sex chromosome aneuploidies
Date:5/2/2012

NEW HAVEN, Conn., May 2, 2012 /PRNewswire/ -- JS Genetics announces the availability of XCAT-KS, its proprietary buccal swab test for the diagnosis of Klinefelter syndrome (KS) and other male sex chromosome aneuploidies. Klinefelter syndrome, a condition in which males have an extra X chromosome, is one of the most common genetic abnormalities in males.  It is estimated that about one in every 500 males has an extra X chromosome.

Klinefelter syndrome can affect physical development resulting in low muscle tone, infertility, gynecomastia and hypogonadism.  KS can also result in language development disorders including delayed speech and social problems such as shyness and moody behavior. However, the diagnosis of KS is not readily apparent on physical exams or by routine testing. Only 25% of KS patients are diagnosed during their lifetime. 

XCAT-KS is a PCR / pyrosequencing based test which identifies Klinefelter syndrome and other male sex chromosome aneuploidies with 100% sensitivity and specificity as detailed in a validation study published in the International Journal of Pediatric Endocrinology (2012:8  23 April 2012). 

The results of the XCAT-KS will typically be available within 3 business days following receipt of the buccal swabs at JS Genetics' CLIA certified laboratory.

In other news, JS Genetics announces that it has been awarded re-accreditation by the College of American Pathologists (CAP).  As part of the biannual re-accreditation program, CAP inspectors examine laboratory staff qualifications, as well as the laboratory's equipment, facilities and records, and the overall management of the laboratory.  The CAP Laboratory Accreditation Program, begun in the early 1960s, is recognized by the US Federal government as being equal to or more stringent than the government's own inspection program and is designed to specifically ensure the highest standard of care for all laboratory patients.

About JS Genetics
JS Genetics Inc., a private company, develops and markets proprietary, high value DNA diagnostic tests for medical conditions in newborns, children, and adolescents. (CLIA ID# 07D1091103; CAP# 72115351)

For more information about JS Genetics or XCAT-KS  visit www.jsgenetics.com.  Physicians who would like to obtain testing kits at no charge can order at www.jsgenetics.com or call 1-888-217-8947.


'/>"/>
SOURCE JS Genetics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Khan Academy and 23andMe Partner to Promote Genetics Education on DNA Day
2. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
3. Genetics Policy Institute (GPI) Files Additional Legal Arguments in Sherley v. Sebelius Stem Cell Case
4. GeneThera, Inc. Acquires Applied Genetics, S.A.
5. deCODE Genetics, in Collaboration with Academic Colleagues, Discovers Three Variants in the Sequence of the Human Genome that Affect the Risk of Thyroid Cancer
6. Cytogenetics - Technologies, Markets and Companies
7. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
8. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
9. Interleukin Genetics Reports Third Quarter 2011 Financial Results
10. Interleukin Genetics, Inc. Announces Conference Call to Discuss Third Quarter 2011 Results
11. Myriad Genetics Receives the "Corporate Spirit of Giving Award" From the Utah Philanthropy Day Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... ... 2017 , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on ... DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of ...
Breaking Biology Technology:
(Date:6/23/2017)... and ITHACA, N.Y. , June 23, ... University, a leader in dairy research, today announced a ... to help reduce the chances that the global milk ... of this dairy project, Cornell University has become the ... the Food Supply Chain, a food safety initiative that ...
(Date:5/23/2017)... 23, 2017  Hunova, the first robotic gym for the rehabilitation and ... launched in Genoa, Italy . The first 30 robots ... the USA . The technology was developed and patented ... the IIT spin-off Movendo Technology thanks to a 10 million euro investment ... please click: ...
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
Breaking Biology News(10 mins):